Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer

BACKGROUND: Recurrent platinum-resistant clear-cell ovarian cancer has a low overall survival duration of 7-8 months, making it a fatal disease. Currently, chemotherapy is the major kind of treatment, but it offers little advantage. Repurposed conventional drugs have recently been found to offer the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinsuwan, Woraporn, Norchai, Phawit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266906/
https://www.ncbi.nlm.nih.gov/pubmed/37323625
http://dx.doi.org/10.1155/2023/2079654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266906/
https://www.ncbi.nlm.nih.gov/pubmed/37323625
http://dx.doi.org/10.1155/2023/2079654

Ejemplares similares